Each pathology image generated through the digitization of diagnostic workflows contains billions of pixels and powerful insights that can be leveraged to accelerate drug discovery and development. In this webinar, industry leaders will share how they are harnessing this valuable data to drive the next breakthroughs in precision medicine.
Attendees will walk away with:
- A comprehensive understanding of the value of real-world data (RWD) in accelerating critical milestones in the development of precision medicine diagnostics and therapies, illustrated with concrete examples and use cases
- Expert insights into the future impact of RWD on precision medicine as digital pathology adoption continues to rise
- A deeper appreciation for the critical role clinical laboratories play, not only in delivering today’s precision medicines diagnostics, but in advancing the novel diagnostics and therapies of tomorrow
Panel
Derek Weich, MD, FCAP
Chief Medical Officer
PathGroup
Ben Freibert, PhD
Principal Informatics Systems Lead, gCS
Computational Catalysts
Genentech, A Member of the Roche Group
Nathan Buchbinder
Chief Strategy Officer
Proscia
About Pathology at Life Speed
Pathology at Life Speed is a webinar series featuring speakers and topics designed to help biopharma companies, biotechs, CROs, academic research centers and commercial laboratories to unlock the full potential of pathology and precision medicine. Learn how new technologies and innovations in pathology can accelerate R&D, and help labs stay ahead of the pace of the market.
The PALS webinar series will explore how:
- Data & AI are rewiring how we discover, develop, and bring to patients life-saving treatments.
- Breakthroughs in biology are transforming patient care, with precision therapies in oncology and beyond.
- Digital pathology, spatial biology, and AI offer new tools to deepen our understanding of disease at a tissue, cellular, and molecular level, and ensure the right patients get on the right drugs.
SOURCE: Proscia
